Partnership to Support 21st Century’s Expansion into New Markets, Enhanced Product Offerings, and Shared Mission to Improve Global Health and Well-Being Grant AvenuePartnership to Support 21st Century’s Expansion into New Markets, Enhanced Product Offerings, and Shared Mission to Improve Global Health and Well-Being Grant Avenue

Grant Avenue Capital Acquires 21st Century Healthcare

Partnership to Support 21st Century’s Expansion into New Markets, Enhanced Product Offerings, and Shared Mission to Improve Global Health and Well-Being

Grant Avenue Acceleration Partner Dave Meadows to Join 21st Century Board of Directors

NEW YORK–(BUSINESS WIRE)–Grant Avenue Capital, LLC (“Grant Avenue”), a healthcare-focused, middle-market private equity firm, today announced the acquisition of 21st Century Healthcare, Inc. (“21st Century” or the “Company”), a leading provider of vitamins, minerals, and supplements (“VMS”) for both humans and pets. Terms of the transaction were not disclosed.

Founded in 1991, 21st Century manufactures and distributes a broad portfolio of VMS products across in-house brands – including Alaska Wild®, Arthri-Flex Advantage®, ImmuBlast®, Herbal Slimming Tea®, VitaJoy® and Zoo Friends® – as well as national brand equivalents and private label offerings. Guided by its mission to improve the health and well-being of individuals, families, and communities worldwide, 21st Century has demonstrated a strong track record of innovation while maintaining rigorous quality and safety standards.

Grant Avenue is partnering with Kirk Neal, 21st Century President and Chief Executive Officer, and his entire team of dedicated professionals, to build on the Company’s position as a trusted partner within the dietary supplements industry by expanding its product portfolio and scaling its operations. Grant Avenue Acceleration Partner Dave Meadows, former President of the Drug Substance Contract Development and Manufacturing Organization division at Cambrex, will join the 21st Century Board of Directors.

“This partnership marks an exciting new chapter for 21st Century and further validates our over 30-year commitment to quality and innovation,” said Mr. Neal. “Grant Avenue’s deep healthcare knowledge, industry network, and operational capabilities will enable us to strengthen our manufacturing footprint, broaden our product offerings, and enhance our contract manufacturing capabilities, while allowing our team to maintain the high quality, best-in-class service our customers expect and trust.”

Alex Ferree, Principal at Grant Avenue, added, “We see a compelling opportunity to build upon 21st Century’s strong momentum by expanding its market reach across both e-commerce and retail channels. As the Company continues to deepen its relationships with customers and partners, and deliver accessible, high-quality wellness products, we look forward to partnering with the 21st Century team to support its next phase of growth.”

Grant Avenue was advised by Lincoln International as lead debt advisor and McGuireWoods LLP as legal counsel.

About Grant Avenue Capital

Grant Avenue Capital is a healthcare-focused, middle-market private equity firm targeting investments alongside forward-thinking management teams that seek an experienced and innovative investor with operational insight and flexible capital to drive business growth. With decades of healthcare investing experience, deep industry knowledge, and a broad network of relationships, Grant Avenue actively supports the strategic and operational initiatives of its investments in pursuit of exceptional outcomes. Grant Avenue partners with companies in a variety of transaction structures, including founder recapitalizations, majority buyouts, minority investments, corporate carve-outs, and special situations. Grant Avenue is committed to delivering outstanding, risk-adjusted returns by actively building world-class companies that enhance patient health, strengthen the health system, and positively impact communities they serve. For more information, visit: https://grantave.com/

About 21st Century Healthcare

21st Century Healthcare is a leading manufacturer of vitamins and supplements dedicated to quality, innovation, and transparency. The Company’s state-of-the-art facilities in Tempe, Arizona, operate under strict Good Manufacturing Practices (GMP), supporting a broad portfolio of products for both humans and pets, including tablets, capsules, powders, and teas. For more information, visit www.21stcenturyvitamins.com.

Contacts

For Media:

Amanda Shpiner/Justin Dechiario

Gasthalter & Co.

Grant-Avenue@gasthalter.com

For Grant Avenue Capital:

Brian Andruskiewicz

CFO & Chief Compliance Officer

info@grantavecap.com

For 21st Century Healthcare:

Kirk Neal

President & CEO

pr@21stcenturyvitamins.com

Market Opportunity
MISSION Logo
MISSION Price(MISSION)
$0.0000002795
$0.0000002795$0.0000002795
+51.57%
USD
MISSION (MISSION) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now?

The post Is Putnam Global Technology A (PGTAX) a strong mutual fund pick right now? appeared on BitcoinEthereumNews.com. On the lookout for a Sector – Tech fund? Starting with Putnam Global Technology A (PGTAX – Free Report) should not be a possibility at this time. PGTAX possesses a Zacks Mutual Fund Rank of 4 (Sell), which is based on various forecasting factors like size, cost, and past performance. Objective We note that PGTAX is a Sector – Tech option, and this area is loaded with many options. Found in a wide number of industries such as semiconductors, software, internet, and networking, tech companies are everywhere. Thus, Sector – Tech mutual funds that invest in technology let investors own a stake in a notoriously volatile sector, but with a much more diversified approach. History of fund/manager Putnam Funds is based in Canton, MA, and is the manager of PGTAX. The Putnam Global Technology A made its debut in January of 2009 and PGTAX has managed to accumulate roughly $650.01 million in assets, as of the most recently available information. The fund is currently managed by Di Yao who has been in charge of the fund since December of 2012. Performance Obviously, what investors are looking for in these funds is strong performance relative to their peers. PGTAX has a 5-year annualized total return of 14.46%, and is in the middle third among its category peers. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 27.02%, which places it in the middle third during this time-frame. It is important to note that the product’s returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund’s [%] sale charge. If sales charges were included, total returns would have been lower. When looking at a fund’s performance, it…
Share
BitcoinEthereumNews2025/09/18 04:05
QNT Technical Analysis Jan 21

QNT Technical Analysis Jan 21

The post QNT Technical Analysis Jan 21 appeared on BitcoinEthereumNews.com. QNT’s MACD histogram showing a positive trend and RSI stabilizing in the neutral zone
Share
BitcoinEthereumNews2026/01/21 23:54
SHIB Alert: First Three-Hour Death Cross Flashes on Chart in 2026, Is It Important?

SHIB Alert: First Three-Hour Death Cross Flashes on Chart in 2026, Is It Important?

The post SHIB Alert: First Three-Hour Death Cross Flashes on Chart in 2026, Is It Important? appeared on BitcoinEthereumNews.com. Shiba Inu is forming a death cross
Share
BitcoinEthereumNews2026/01/22 00:26